ESLIFY 600MG TABLET
₹171*
MRP ₹190
10% off
₹161*
MRP ₹190
15% CB
₹29 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
ESLIFY 600MG TABLET belongs to the class of medications called ‘antiepileptic drugs’ used to treat epilepsy (fits). Epilepsy is a sudden rush of electricity in the brain. In epilepsy the brain's electrical rhythms become imbalanced, resulting in recurrent seizures. It can cause changes in your behavior, movements or feelings and levels of consciousness.
ESLIFY 600MG TABLET contains ‘Eslicarbazepine acetate’ which is used to treat epilepsy or seizures. It inactivates certain channels in the brain that passes electronic signals. This effect helps to decrease abnormal activity or electrical disturbance in the brain, thereby preventing epilepsy episodes. It reduces the frequency and number of seizure episodes.
You should use this medicine exactly as prescribed by the doctor. ESLIFY 600MG TABLET may cause side effects such as dizziness, drowsiness, fatigue and visual disturbances. These side effects usually resolve without requiring treatment. However, if any of these side effects persist or get worse, inform your doctor immediately.
It is not recommended to take ESLIFY 600MG TABLET if you are allergic to its contents or other medicines used to treat epilepsy. Before taking ESLIFY 600MG TABLET, inform your doctor if you have heart rhythm disorder, heart failure and primary generalized seizures (seizures that involve both sides of the brain). Some people may also experience suicidal thoughts. Seek medical attention immediately in such cases. ESLIFY 600MG TABLET should be used with caution in pregnant and breastfeeding women. ESLIFY 600MG TABLET is not recommended for children below six years of age, severe liver diseases, and severe kidney diseases. ESLIFY 600MG TABLET may require dose adjustments in elderly people. Do not take alcohol while using ESLIFY 600MG TABLET as it may increase the risk of side effects. ESLIFY 600MG TABLET may cause dizziness or drowsiness, so do not drive or operate heavy machinery if you feel dizzy.
ESLIFY 600MG TABLET contains ‘Eslicarbazepine acetate’ which is used in the treatment of epilepsy or seizures. It acts by decreasing the electrical disturbance in the brain. It can be given as monotherapy in adults who are newly diagnosed with epilepsy. It can also be used in combination with other antiepileptic drugs in children above 6 years and adults to treat partial-onset seizures (seizures that affect one part of the brain).
Inform your doctor immediately if you notice cognitive disturbances such as confusion, impaired coordination and memory impairment while using ESLIFY 600MG TABLET. The doctor may make dose adjustments based on your condition. Inform your doctor if you notice any suicidal thoughts or behaviour. ESLIFY 600MG TABLET may cause hyponatremia (decreased sodium levels in the blood) and cause worsening of seizures or decreased consciousness or cognitive disturbances. So, the doctor may advise you to monitor sodium levels while using ESLIFY 600MG TABLET. Inform your doctor about all the prescription or non-prescription medicines you are taking as some medicines may increase PR interval. The use of ESLIFY 600MG TABLET with these medications can worsen the health condition. If you develop a skin rash, or other skin-related problems while using ESLIFY 600MG TABLET, inform your doctor immediately. Please do not stop taking the medication abruptly, as it may increase seizure frequency. So, the doctor gradually decreases the dose before completely stopping the treatment.
Drug-Drug Interactions: ESLIFY 600MG TABLET may interact with other antiepileptic drugs (phenytoin, carbamazepine, oxcarbazepine), medicines used to lower cholesterol levels (simvastatin and rosuvastatin), oral contraceptives, an antidepressant (amitriptyline) and blood thinner (warfarin).
Drug-Food Interactions: Avoid alcohol consumption while taking ESLIFY 600MG TABLET as it may increase dizziness or drowsiness.
Drug-Disease Interactions: ESLIFY 600MG TABLET should not be used in patients with heart rhythm disorders, heart failure, severe liver or kidney impairment and primary generalized seizures (seizures that involve both sides of the brain).
Epilepsy: It is a brain-related problem in which there is a sudden rush of electricity in the brain. This sudden, uncontrolled disturbance in nerve cells or electrical activity in the brain, results in recurrent seizures (fits), sometimes leading to an unconscious state. In patients with seizures, the typical brain electrical pattern is disrupted by sudden bursts of electrical impulses that affect an individual's consciousness, movements or sensations. Seizures are of two types: generalized and partial seizures. Generalized seizures affect the entire brain, whereas partial seizures affect only a part of the brain. Seizures can cause uncontrollable muscle twitches and spasms. Stronger seizures may cause people to become confused or unconscious. Possible causes include high fever, trauma, genetic disorder, brain injury or stroke.
Alcohol
Unsafe
Avoid alcohol consumption as it may increase the risk of side-effects such as dizziness or drowsiness and worsen the condition.
Pregnancy
Caution
ESLIFY 600MG TABLET should be used with caution in pregnant women as it may cause harmful effects to the unborn baby.
Breast Feeding
Caution
ESLIFY 600MG TABLET should be used with caution in breastfeeding mothers as it may cause harmful effects to the nursing baby.
Driving
Caution
ESLIFY 600MG TABLET may cause dizziness or drowsiness, so do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
ESLIFY 600MG TABLET is probably safe in patients with mild to moderate liver diseases. However, in patients with severe liver diseases, ESLIFY 600MG TABLET is contraindicated as this medicine may worsen the health condition.
Kidney
Caution
ESLIFY 600MG TABLET may require dose adjustments when used in patients with kidney diseases. However, in patients with severe kidney impairment, ESLIFY 600MG TABLET is contraindicated as this medicine may worsen the health condition.
Children
Caution
ESLIFY 600MG TABLET is not recommended for children below 6 years of age. In children above 6 years, dose adjustment may be required based on body weight.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes